Heliospectra delivered a solid Q1'19 report but has not maintained the high order intake growth rate shown in 2018, and we have therefore revised our short-term estimates. We are, however, upbeat about its recent initiatives and argue that the expansion into Canada, increased focus on new products and recently strengthened cash position reflects that it is gearing up for long-term growth.